1.Suggestions for the diagnostic criteria of alcoholic hepatopathy.
Chinese Journal of Hepatology 2002;10(2):141-141
Alanine Transaminase
;
blood
;
Aspartate Aminotransferases
;
blood
;
Female
;
Humans
;
Liver
;
pathology
;
Liver Diseases, Alcoholic
;
blood
;
diagnosis
;
Male
;
gamma-Glutamyltransferase
;
blood
3.A Case of Hepatopulmonary Syndrome in a Patient with Child-Pugh Class A Liver Cirrhosis.
Jung Sun KIM ; Changhwan KIM ; Gye Su KIM ; Dal Soo LIM ; Hweung Kon HWANG ; Young Moo RO
Tuberculosis and Respiratory Diseases 2009;66(1):47-51
Hepatopulmonary syndrome (HPS) is characterized by a defect in arterial oxygenation that's induced by pulmonary vascular dilatation in the setting of liver disease. Some studies have shown the relationship between the presence of the HPS and the severity of liver disease, but there are only rare cases of HPS inpatient with Child-Pugh class A liver cirrhosis. We report here on a case of a 58 years-old male who suffered from progressive dyspnea for the previous few years. He was diagnosed with alcoholic liver cirrhosis 5 years previously. There was no significant abnormality on the chest radiograph and transthoracic echocardiography, but the arterial blood gas analysis revealed severe hypoxemia. Contrast-enhanced transesophageal echocardiograpy with agitated saline demonstrated a delayed appearance of microbubbles in the left cardiac chambers. Thus, he was finally diagnosed with HPS. This case suggests that we should consider HPS when a patient with compensated liver cirrhosis has unexplained dyspnea.
Anoxia
;
Blood Gas Analysis
;
Dihydroergotamine
;
Dilatation
;
Dyspnea
;
Echocardiography
;
Hepatopulmonary Syndrome
;
Humans
;
Inpatients
;
Liver
;
Liver Cirrhosis
;
Liver Cirrhosis, Alcoholic
;
Liver Diseases
;
Liver Transplantation
;
Male
;
Microbubbles
;
Oxygen
;
Thorax
4.Serum alcohol dehydrogenase activity in alcoholic liver diseases.
Yuhong HUANG ; Yichun WANG ; Bingyuan WANG ; Baoyu FU
Chinese Journal of Hepatology 2002;10(1):24-24
Adult
;
Alanine Transaminase
;
blood
;
Alcohol Dehydrogenase
;
blood
;
genetics
;
Alkaline Phosphatase
;
blood
;
Bilirubin
;
blood
;
Female
;
Humans
;
Liver Diseases, Alcoholic
;
blood
;
genetics
;
Male
;
gamma-Glutamyltransferase
;
blood
5.Death by Spontaneous Hemoperitoneum due to the Rupture of Capsular Vasculature in Hepatocellular Carcinoma Patient: A Case Report.
Minsung CHOI ; Byung Ha CHOI ; Hyoung Joong KIM
Korean Journal of Legal Medicine 2013;37(1):42-45
Hepatocellular carcinoma (HCC) is one of the leading causes of death in Korea. Chronic hepatitis, alcoholic liver disease and liver cirrhosis are predisposing factor of HCC. Bleeding tendency and hemorrhage resulting from reduced production of coagulation factors or portal hypertension are not uncommon in HCC, moreover spontaneous hemoperitoneum also can occur. Spontaneous hemoperitoneum is a complication of HCC, that is caused by the rupture of HCC mass which abuts on the hepatic capsule. However hemoperitoneum also occurs due to the rupture of vasculature of the mass. Emergency laparotomy is the recommended treatment, however these patients exhibit poor prognosis because of hemodynamic instability followed by combined liver disease. Herein, we report a case of spontaneous hemoperitoneum due to the rupture of subcapsular vessels with invasion of HCC in a 39-years-old man, whose tumor was left undetected.
Blood Coagulation Factors
;
Carcinoma, Hepatocellular
;
Cause of Death
;
Emergencies
;
Hemodynamics
;
Hemoperitoneum
;
Hemorrhage
;
Hepatitis, Chronic
;
Humans
;
Hypertension, Portal
;
Korea
;
Laparotomy
;
Liver Cirrhosis
;
Liver Diseases
;
Liver Diseases, Alcoholic
;
Prognosis
;
Rupture
6.Hemorheological Alteration in Patients Clinically Diagnosed with Chronic Liver Diseases.
Bohyun JANG ; Ji Won HAN ; Pil Soo SUNG ; Jeong Won JANG ; Si Hyun BAE ; Jong Young CHOI ; Young I CHO ; Seung Kew YOON
Journal of Korean Medical Science 2016;31(12):1943-1948
Since liver function is changed by chronic liver diseases, chronic liver disease can lead to different hemorheological alterations during the course of the progression. This study aims to compare alterations in whole blood viscosity in patients with chronic liver disease, focusing on the gender effect. Chronic liver diseases were classified into three categories by patient’s history, serologic markers, and radiologic findings: nonalcoholic fatty liver disease (NAFLD) (n = 63), chronic viral hepatitis B and C (n = 50), and liver cirrhosis (LC) (n = 35). Whole blood viscosity was measured by automated scanning capillary tube viscometer, while liver stiffness was measured by transient elastography using FibroScan®. Both systolic and diastolic whole blood viscosities were significantly lower in patients with LC than NAFLD and chronic viral hepatitis (P < 0.001) in male patients, but not in female patients. In correlation analysis, there were inverse relationships between both systolic and diastolic whole blood viscosity and liver stiffness (systolic: r = −0.25, diastolic: r = −0.22). Whole blood viscosity was significantly lower in male patients with LC than NAFLD or chronic viral hepatitis. Our data suggest that whole blood viscosity test can become a useful tool for classifying chronic liver disease and determining the prognosis for different types of chronic liver diseases.
Blood Viscosity
;
Capillaries
;
Elasticity Imaging Techniques
;
Female
;
Hemorheology
;
Hepatitis
;
Hepatitis B
;
Humans
;
Liver Cirrhosis
;
Liver Diseases*
;
Liver*
;
Male
;
Non-alcoholic Fatty Liver Disease
;
Prognosis
7.The prevalence of diabetes mellitus in chronic liver disease.
Hyun Chul LEE ; Kap Bum HUH ; Sung Kwan HONG ; Hyun Jung ROH ; Byung Joo CHOI ; Sang Hoon AN ; Il SUH ; Kwang Hyup HAN
Korean Journal of Medicine 1999;57(3):281-287
The insulin resistance and the altered glucose metabolism in chronic liver disease increase the alteration of glucose intolerance and the prevalence of diabetes mellitus. The prevalence of DM is higher in advanced cirrhosis than in early cirrhosis and higher in C-viral hepatitis or alcoholic liver disease than in B-viral hepatitis. The purpose of this study is to assess the prevalence of DM in chronic liver disease in Korea. METHODS: We reviewed the medical records of 417 patients with chronic liver disease who visit the Yonsei University Sevrance Hospital from January 1994 to March 1998. We examined fasting blood sugar, biochemical study and abdominal ultrasonography. DM was defined on the basis of fasting hyperglycemia (fasting blood sugar exceeding 140 mg/dl) at least two consecutive samples or active treatment with insulin or oral hypoglycemic agents. RESULTS:1) The DM prevalence was 16.8%(70 cases) in total patients and 25.0% (56 cases) in cirrhotic patients. 2) According to sex, there was no statistically significant difference in DM prevalence(16.8% in men and 18.1% in women P=0.78). 3) The DM prevalence was increased with increasing of age(0% in below 30 years, 4.9% in 31-40, 19.6% in 41-50, 22.9% in 51-60, 21.3% in 61-70 and 44.4% in over 71 years, p<0.01). 3) According to severity of liver disease, the DM prevalence was higher in uncompensated cirrhosis than in compensated cirrhosis(2.3% in chronic viral carrier, 8.8% in chronic hepatitis, 17.9% in cirrhosis Child class A, 33.9% in class B, 29.5% in class C). 4) According to cause of liver disease, the DM prevalence was higher in C-viral hepatitis and alcoholics than in B-viral hepatitis(12.1% in B-viral hepatitis, 35.1% in C-viral hepatitis, 40.0% in alcoholics). CONCLUSION: The prevalence of diabetes in the patients with chronic liver disease is much higher than in general population. And the DM prevalence is increased in advanced cirrhosis and C-viral or alcoholic hepatitis. The early diagnosis and treatment of DM in chronic liver disease patients are important.
Alcoholics
;
Blood Glucose
;
Child
;
Diabetes Mellitus*
;
Early Diagnosis
;
Fasting
;
Female
;
Fibrosis
;
Glucose
;
Glucose Intolerance
;
Hepatitis
;
Hepatitis, Alcoholic
;
Hepatitis, Chronic
;
Humans
;
Hyperglycemia
;
Hypoglycemic Agents
;
Insulin
;
Insulin Resistance
;
Korea
;
Liver Diseases*
;
Liver Diseases, Alcoholic
;
Liver*
;
Male
;
Medical Records
;
Metabolism
;
Prevalence*
;
Ultrasonography
8.A Case of Transfusion-related Acute Lung Injury.
Ji Young HUH ; Tae Hee HAN ; Ji Weon SEO ; Dong Chan KIM ; Dong Hwan ROH ; Kyou Sup HAN
Korean Journal of Blood Transfusion 2005;16(2):250-254
Transfusion-related acute lung injury (TRALI) is defined as a new episode of acute lung injury that occurs during or within 6 hours of a completed transfusion, which has been the leading cause of transfusion-related death. We report a case of TRALI in a 63-year old man with alcoholic liver disease. He developed hypoxemia and non-cardiogenic pulmonary edema after red blood cell transfusion. Given an oxygen support, he recovered after 4 days.
Acute Lung Injury*
;
Anoxia
;
Blood Group Incompatibility
;
Erythrocyte Transfusion
;
Humans
;
Liver Diseases, Alcoholic
;
Middle Aged
;
Oxygen
;
Pulmonary Edema
10.Blood Pressure and the Risk of Death From Non-cardiovascular Diseases: A Population-based Cohort Study of Korean Adults.
Jeoungbin CHOI ; Jieun JANG ; Yoonsuk AN ; Sue K PARK
Journal of Preventive Medicine and Public Health 2018;51(6):298-309
OBJECTIVES: The objective of this study was to assess the relationship between systolic and diastolic blood pressure (SBP, DBP) and the risk of death from specific causes other than cardiovascular diseases. METHODS: We calculated the risk of specific death by SBP and DBP categories for 506 508 health examinees in 2002-2003 using hazard ratios (HRs) and 95% confidence intervals (CIs) in a Cox proportional hazards model. RESULTS: Compared to normal levels (SBP < 120 or DBP < 90 mmHg), stage I systolic and diastolic hypertension (SBP 140-159, DBP 85- 89 mmHg, respectively) were associated with an increased risk of death from diabetes mellitus, alcoholic liver disease, and renal failure (HR, 1.83; 95% CI, 1.51 to 2.22; HR, 1.24; 95% CI, 1.06 to 1.46; HR, 2.30; 95% CI, 1.64 to 3.21; HR, 1.67; 95% CI, 1.27 to 2.20; HR, 1.99; 95% CI, 1.41 to 2.81; HR, 1.31; 95% CI, 0.99 to 1.73, respectively), but a decreased risk of death from intestinal pneumonia (HR, 0.64; 95% CI, 0.42 to 0.98; HR, 0.59; 95% CI, 0.39 to 0.91). Only stage II systolic hypertension (SBP ≥160 mmHg) was associated with an increased risk of death from pneumonia, liver cirrhosis, and intestinal ischemia (HR, 1.54; 95% CI, 1.19 to 1.98; HR, 1.46; 95% CI, 1.00 to 2.15; HR, 3.77; 95% CI, 1.24 to 11.40, respectively), and stage I and II diastolic hypertension (SBP 140-159 and ≥160 mmHg) were associated with an increased risk of death from intestinal ischemia (HR, 3.07; 95% CI, 1.27 to 7.38; HR, 4.39; 95% CI, 1.62 to 11.88, respectively). CONCLUSIONS: An increase in blood pressure levels may alter the risk of death from certain causes other than cardiovascular diseases, a well-known outcome of hypertension, although the mechanism of these associations is not well documented.
Adult*
;
Blood Pressure*
;
Cardiovascular Diseases
;
Cohort Studies*
;
Diabetes Mellitus
;
Humans
;
Hypertension
;
Ischemia
;
Liver Cirrhosis
;
Liver Diseases, Alcoholic
;
Pneumonia
;
Proportional Hazards Models
;
Renal Insufficiency